No Detail Found!

Dissolution Rate Enhancement of New Co-crystals of Ezetimibe with Maleic Acid and Isonicotinamide.

Author(s)
Li Wen School of Pharmaceut ical Sciences, Zhengzhou University, Zhengzhou, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, China; Key Labo ratory of State Ministry of Education for Pharmaceutical Technology, Zhengzhou, China
NG Xi School of Chemical Engineering and Energy, Zhengzhou University, Zhengzhou, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, China; Key Labo ratory of State Ministry of Education for Pharmaceutical Technology, Zhengzhou, China
Sun K School of Chemical Engineering and Energy, Zhengzhou University, Zhengzhou, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, China; Key Labo ratory of State Ministry of Education for Pharmaceutical Technology, Zhengzhou, China
Fu Ling School of Pharmaceut ical Sciences, Zhengzhou University, Zhengzhou, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, China; Key Labo ratory of State Ministry of Education for Pharmaceutical Technology, Zhengzhou, China
Ding Li N School of Pharmaceut ical Sciences, Zhengzhou University, Zhengzhou, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, China; Key Labo ratory of State Ministry of Education for Pharmaceutical Technology, Zhengzhou, China
Zhao Man School of Chemical Engineering and Energy, Zhengzhou University, Zhengzhou, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, China; Key Laboratory of State Ministry of Education for Pharmaceutical Technology, Zhengzhou, China
Yu Yu-zhen School of Chemical Engineering and Energy, Zhengzhou University, Zhengzhou, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, China; Key Laboratory of State Ministry of Education for Pharmaceutical Technology, Zhengzhou, China
Hu Yan-jie School of Chemical Engineering and Energy, Zhengzhou University, Zhengzhou, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, China; Key Laboratory of State Ministry of Education for Pharmaceutical Technology, Zhengzhou, China
Abstract
Ezetimibe (EZT) is a selective cholesterol absorption inhibitor with poor aqueous solubility (0.012mg/ml 23oC) and low oral bioavailability (about 35-65% for a once 10mg dose). The present study illustrates the preparation and characterization of two new co-crystals of ezetimibe using maleic acid and isonicotinamide as the coformers by solid grinding method. The co-crystal structures were characterized by X-ray powder diffraction (PXRD), differential scanning calorimetry (DSC), infrared spectroscopy (IR) techniques. Crystallinity and surface morphological characteristics of these prepared co-crystals were observed by scanning electron microscope (SEM). Dissolution rate tests demonstrated that both of the new co-crystals showed significant improvement in sodium lauryl sulfate -sodium acetate buffer solution (PH=4.5) at 15min and 20min. This study enriched the types of EZT co-crystals and identified that pharmaceutical co-crystal engineering technique play an important role in the dissolution rate enhancement of ezetimibe.
Publication Details
Page(s) 1501-1507
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 32, Issue: 4, Year: 2019

Request the full text from PASTIC

Keywords
dissolution, isonicotinamide co-crystal
0

Citations

0

Downloads

63

Views